Pfizer 有没有两把萨子？

CrisisInvesting

这回好象又LEAD领先了！第一个get approval by US panel for its RSV vaccine....

Pfizer’s RSV Vaccine Gets US Panel’s Backing for Safety
Nacha Cattan
Nacha Cattan
Bloomberg News

Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of US advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

Members of the panel that advises the Food and Drug Administration voted 7-4 Tuesday that the data presented by the drugmaker show the safety of the vaccine developed to prevent RSV. The same panel will next vote on whether the data show the vaccine is effective. The FDA doesn’t have to follow the recommendations of the Vaccines and Related Biological Products Advisory Committee, but it usually does. ...